|1.||Rosso, Marisa: 3 articles (01/2010 - 06/2007)|
|2.||Muñoz, Miguel: 3 articles (01/2010 - 06/2007)|
|3.||Coveñas, Rafael: 2 articles (01/2010 - 06/2007)|
|4.||González-Ortega, Ana: 1 article (01/2010)|
|5.||Esteban, Francisco: 1 article (04/2008)|
|6.||González-Moles, Miguel A: 1 article (04/2008)|
|7.||Aguilar, Francisco J: 1 article (04/2008)|
|8.||Redondo, Maximino: 1 article (04/2008)|
|9.||González-Moles, Miguel Angel: 1 article (06/2007)|
|10.||Robles, María José: 1 article (06/2007)|
|1.||Retinoblastoma (Glioblastoma, Retinal)
06/01/2007 - "The purpose of this study was to demonstrate the presence of neurokinin-1 receptors in the human retinoblastoma cell lines WERI-Rb-1 and Y-79 and to study the growth inhibitory capacity of the neurokinin-1 receptor antagonist L-732,138 against those cell lines. "
06/01/2007 - "Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138."
06/01/2007 - "The authors also sought to demonstrate that the administration of L-732,138 or L-733,060 induces apoptosis in retinoblastoma cells and that neurokinin-1 receptors and substance P are present in primary retinoblastoma. "
|2.||Melanoma (Melanoma, Malignant)
01/01/2010 - "The aim of this study was to demonstrate an antitumor action of L-732,138 against three human melanoma cell lines (COLO 858, MEL HO, COLO 679). "
01/01/2010 - "We found that L-732,138 elicits cell growth inhibition in a concentration dependent manner in the melanoma cells studied. "
01/01/2010 - "These findings indicate that the NK-1 receptor antagonist L-732,138 could be a new antitumor agent in the treatment of human melanoma. "
01/01/2010 - "The specific antitumor action of L-732,138 occurred through the NK-1 receptor and melanoma cell death was by apoptosis. "
01/01/2010 - "The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines."
|1.||Neurokinin-1 Receptors (Neurokinin 1 Receptor)